NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
Provision of Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabe...
Buyer
NHS England
Value
£1,516,353,164
Published
21 Mar 2025
Closes
21 Mar 2025
Procurement details
Source
Find a Tender
Region
Lambeth
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
33690000
Various medicinal products
Lots
Lot 1 NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
Value not provided
Delivery: UK · United Kingdom
Documents
Unlock document linkPreliminary market engagement notice on Find a Tender
21 Mar 2025
Preliminary market engagement notice on Find a Tender
Market engagement notice · UK2 · Web page
Contains public sector information licensed under the Open Government Licence v3.0.